Abstract
Three acidic phospholipases A2 from Indian cobra (Naja naja naja) venom inhibited platelet aggregation in platelet rich plasma induced separately by ADP, collagen and epinephrine with different potencies. The order of inhibition was epinephrine > collagen > ADP. They did not inhibit platelet aggregation induced by arachidonic acid (10 μM). The inhibition was dependent on concentration of the protein and the time of incubation of the phospholipases A2 with platelet rich plasma. Parabromophenacyl bromide modified PLA2 enzymes lost their enzymatic activity as well as platelet aggregation inhibition activity suggesting the involvement of catalytic function in platelet aggregation inhibitory activity.
Similar content being viewed by others
References
Kini RM, Evans HJ: A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon 27: 613–635, 1989
Huang HC, Yeh HI, Ouyang C: Mechanism of the platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon 22: 243–251, 1984
Kini RM, Evans HJ: Effects of snake venom proteins on blood platelets. Toxicon 28: 1387–1421, 1990
Chen RH, Chen YC: Isolation of an acidic phospholipase A2 from the venom of Agkistrodon acutus (Five pace snake) and its effect on platelet aggregation. Toxicon 27: 675–682, 1989
Kini RM, Evans HJ: Correlation between the enzymatic activity, anticoagulant and antiplatelet effects of phospholipase A2 isoenzyme from Naja nigricollis venom. Thromb Haemostat 60: 170–173, 1988
Li YS, Liu KF, Wang QC, Ran YL, Tu GC: A platelet function inhibitor purified from Vipera russelli siamensis (Smith) snake venom. Toxicon 23: 895–903, 1985
Ouyang C, Huang TF: Effect of the purified phospholipases A2 from snake and bee venoms on rabbit platelet function. Toxicon 22: 705–718, 1984
Ouyang C, Teng CM, Chen YC: Properties of fibrinogen degradation products produced by α and β-fibrinogenases of Trimeresurus mucrosquamatus snake venom. Toxicon 17: 121–126, 1979
Prasad BN, Kemparaju K, Bhatt KGS, Gowda TV: A platelet aggregation inhibitor phospholipase A2 from Russell's viper (Vipera russelli) venom: Isolation and characterization. Toxicon 34: 1173–1185, 1996
Takagi J, Sekiya F, Kasahara K, Inada Y, Saito Y: Venom from southern copperhead snake (Agkistrodon contortrix contortrix) II. A unique phospholipase A2 that induces platelet aggregation. Toxicon 26: 199–206, 1988
Teng CM, Kuo YP, Lee LG, Ouyang C: Effect of cobra venom phospholipase A2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophosphatidylcholine. Thromb Res 44: 875–886, 1986
Singleton WS, Gray MS, Brown ML, White JL: Chromatographically homogenous lecithin from egg phospholipids. J Am Oil Chem Soc 42: 53–56, 1965
Rudrammaji LMS, Gowda TV: Purification and characterization of three Acidic, cytotoxic phospholipases A2 from Indian Cobra (Naja naja naja) venom. Toxicon 36: 921–932, 1998
Bhat M, Gowda TV: Purification and characterization of myotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom. Toxicon 27: 861–874, 1989
Born GVR: Quantitative investigation into the aggregation of blood platelets. J Physiol 162: 67–72, 1962
Condrea E, Fletcher JE, Rapuano BE, Yang CC, Rosenberg P: Effect of modification of one histidine residue on the enzymatic and pharmacological properties of a toxic phospholipase A2 from Naja nigricollis snake venom and less toxic phospholipases A2 from Haemachatus haemachatus and Naja naja atra snake venoms. Toxicon 19: 61–71, 1981
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin-phenol reagent. J Biol Chem 193: 265–275, 1951
Zucker MB: Platelet aggregation measured by photometric method. Meth Enzymol 169: 117–133, 1989
Mills PCB, Robb IA, Roberts GCK: The release of nucleotides, 5-hydroxy tryptamine and enzymes from human platelets during aggregation. J Physiol 195: 715–729, 1968
O'Brien JRA: Comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J Clin Path 17: 275–281, 1964
Salzman EW, Chamberr DA, Neri LL: Possible mechanism of aggregation of blood platelets by adenosine diphosphate. Nature 210: 167–169, 1966
Hovig T: Aggregation of rabbit blood platelets produced in vitro by saline ‘extracts’ of tendons. Thromb Diather Maemorrh 9: 248–263, 1963
Spaet TH, Zucker MB: Mechanism of platelet plug formation and role of adenosine diphosphate. Am J Physiol 206: 1267–1274, 1964
Hamberg M, Svensskon J, Samuelsson B: Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994, 1981
Fratantoni JC, Poindexter BJ: Characterization of the platelet response to exogenous arachidonic acid. Thromb Res 22: 157–166, 1981
Li YS, Liu KF, Wang QC: Mechanism of action of the platelet function inhibitor purified from Vipera russeli siamensis snake venom. Toxicon 24: 875–883, 1986
Laing GD, Kamiguti AS, Wilkinson MC, Lowe GM, Theakston RDG: Characterization of a purified phospholipase A2 from the venom of the Papuan black snake (Pseudechis papuanus). Biochim Biophys Acta 1250: 237–143, 1995
Kemparaju K, Krishnakanth TP, Veerabasappa gowda T: Purification and characterization of a platelet aggregation inhibitor acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) venom. Toxicon 35: 1659–1671, 1999
Kini RM, Evans HJ: Effect of phospholipase A2 enzymes on platelet aggregation. In: Venom Phospholipase A2 Enzymes. Structure, Function and Mechanism. John Wiley and Sons, 1997, pp 369–387
Kanagi R, Koizumi K, Masuda T: Limited hydrolysis of platelet membrane phospholipids on the proposed phospholipase susceptible domain in platelet membrane. J Biol Chem 256: 1177–1182, 1981
Teng CM, Chen YH, Ouyang C: Biphasic effect on platelet aggregation by phospholipase A2 purified from Vipera russelli snake venom. Biochim Biophys Acta 772: 393–402, 1984
Silver MJ, Smith JB, Ingerman C, Kocsis JJ: Arachidonic acid induced platelet aggregation and prostaglandin formation. Prostaglandins 4: 863–866, 1973
Joist JH, Dolezel G, Cucuianu MP, Wishizawe EE, Mustard JF: Inhibition and potentiation of platelet function by lysolecithin. Blood 49: 101, 1977
Feiyge MAH, Heemskerk JWM, Hornistra G: Membrane fluidity of activated and nonactivated human blood platelets. Biochim Biophys Acta 1025: 1173–1178, 1990
Shatil SJ, Anaya-Galimbodo R, Bennett J, Colman RW, Cooper RA: Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 55: 636–643, 1975
Shatil SJ, Cooper RA: Membrane micro viscosity and human platelet function. Biochemistry 15: 4832–4837, 1976
Fuly AL, Machado OLT, Alves EW, Carlini CR: Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lacheis muta (Bushmaster) snake venom. Thromb Haemostat 78: 1372–1380, 1997
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rudrammaji, L., Machiah, K.D., Krishna Kantha, T. et al. Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom. Mol Cell Biochem 219, 39–44 (2001). https://doi.org/10.1023/A:1011002606505
Issue Date:
DOI: https://doi.org/10.1023/A:1011002606505